TOPIRAMATE AND WEIGHT LOSS

被引：0

作者：

Alshammari, Elham ^{[1
]}

Alshammari, Ahlam ^{[2
]}

机构：

[1] Princess Nourah Bint Abdul Rahman Univ, Fac Pharm, Dept Pharm, Airport Rd, Riyadh, Saudi Arabia

[2] Med Serv Author, Mil Med Complex, Kuwait, Kuwait

来源：

INTERNATIONAL JOURNAL OF HEALTH MEDICINE AND CURRENT RESEARCH-IJHMCR | 2019年 / 4卷 / 04期

关键词：

Topiramate; Epilepsy; Antiepileptic drugs (AEDs); Obesity; Weight loss; PHENTERMINE/TOPIRAMATE; TRIALS;

D O I：

10.22301/IJHMCR.2528-3189.1501

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The purpose of this study is to examine the effectiveness of topiramate in promoting weight loss among obese patients. The study was inspired by the fact that men and women, in addition to the stereotyped teenager are affected by eating disorders. The general scope of this paper will comprise of the evaluation of the effectiveness of topiramate in weight loss amongst obese patients. The research achieves this through a review of past literature. In sum, the reviewed studied found that the use of topiramate was associated with an increase in positive outcomes. Most of the positive outcomes were linked with weight reduction among overweight and obese patients. The review also revealed that the administration of the drug reduced the adverse effects with psychotic drugs, minimized food cravings, alcohol and smoking. Moreover, the combination of the drug with other antiepilepsy medications had more positive outcomes than when used as a monotherapy. Copyright (C) 2019, Elham Alshammari.

引用

页码：1501 / 1505

页数：5

共 50 条

[21] Loss of taste and smell during treatment with topiramate [J].

Ghanizadeh, A. .

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2009, 14 (2-3) :E137-E138

[22] Topiramate and Metformin: Initial Insights into PCOS Weight Management and the Need for Further Research [J].

Amiri, Mina ;

Azziz, Ricardo .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,

[23] Loss of taste and smell during treatment with topiramate [J].

A. Ghanizadeh .

Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2009, 14 :e137-e138

[24] Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy [J].

Iwaki, Hirotaka ;

Jin, Kazutaka ;

Fujikawa, Mayu ;

Nakasato, Nobukazu ;

Kaneko, Sunao .

EPILEPSY & BEHAVIOR, 2018, 83 :87-91

[25] Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes [J].

Yasser Khazaal ;

Daniele Fabio Zullino .

European Journal of Clinical Pharmacology, 2007, 63 :891-892

[26] Weight Changes with Topiramate in Korean Overweight Epileptic Patients [J].

Sung, Seo Young ;

Cho, Yong Yuan ;

Lee, Sang Do .

KOREAN JOURNAL OF FAMILY MEDICINE, 2008, 29 (01) :20-25

[27] Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme [J].

Safavi, R. ;

Lih, A. ;

Kirkpatrick, S. ;

Haller, S. ;

Bailony, M. R. .

OBESITY SCIENCE & PRACTICE, 2019, 5 (05) :468-478

[28] The Influence of Weight-Loss Expectations on Weight Loss and of Weight-Loss Satisfaction on Weight Maintenance in Severe Obesity [J].

Calugi, Simona ;

Marchesini, Giulio ;

El Ghoch, Marwan ;

Gavasso, Ilaria ;

Dalle Grave, Riccardo .

JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2017, 117 (01) :32-38

[29] Benefits of Adjuvant Medical Weight Loss Intervention in Setting of Weight Regain and Inadequate Weight Loss After Weight Loss Surgery [J].

Abel, Stuart A. ;

English, Wayne J. ;

Duke, Meredith C. ;

Williams, D. Brandon ;

Aher, Chetan, V ;

Broucek, Joseph R. ;

Spann, Matthew D. .

AMERICAN SURGEON, 2023, 89 (05) :1857-1863

[30] A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus [J].

Li, Qingqin S. ;

Lenhard, James M. ;

Zhan, Yiping ;

Konvicka, Karel ;

Athanasiou, Maria C. ;

Strauss, Richard S. ;

Francke, Stephan .

PHARMACOGENETICS AND GENOMICS, 2016, 26 (02) :53-65

← 1 2 3 4 5 →